High-throughput imaging: Focusing in on drug discovery in 3D

Methods

Volumn 96, Issue , 2016, Pages 97-102

  Li, Linfeng ^a   Zhou, Qiong ^a   Voss, Ty C ^c   Quick, Kevin L ^c   LaBarbera, Daniel V ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^c PERKINELMER INC   (United States)

Author keywords

3D image analysis software; 3D tissue culture; High content screening; High throughput imaging; Multicellular tumor spheroids; Organoids

Indexed keywords

COMPUTER; COMPUTER PROGRAM; CYTOPLASM; DRUG DEVELOPMENT; HIGH CONTENT SCREENING; HIGH THROUGHPUT IMAGING; HIGH THROUGHPUT SCREENING; HUMAN; IMAGING; IMAGING SYSTEM; MOLECULAR LIBRARY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCREENING; THREE DIMENSIONAL IMAGING; TOXICITY TESTING; TUMOR SPHEROID; CELL SURVIVAL; DEVICES; DRUG EFFECTS; DRUG SCREENING; IMAGE PROCESSING; LIVER CELL; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PHARMACOLOGY; PROCEDURES; SOFTWARE; STATISTICS AND NUMERICAL DATA; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENT; MOLECULAR LIBRARY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DISCOVERY; DRUG SCREENING ASSAYS, ANTITUMOR; HEPATOCYTES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; SMALL MOLECULE LIBRARIES; SOFTWARE; SPHEROIDS, CELLULAR;

EID: 84958179628     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2015.11.013     Document Type: Review

References (53)

1. Srivastava M., Simakov O., Chapman J., Fahey B., et al. Nature 2010, 466:720-726.
2. Wilson H.V. Science 1907, 25:912-915.
3. Lancaster M.A., Knoblich J.A. Science 2014, 345:1247125.
4. Ranga A., Gjorevski N., Lutolf M.P. Adv. Drug Deliv. Rev. 2014, 69-70:19-28.
5. Sutherland R.M., McCredie J.A., Inch W.R. J. Natl Cancer Inst. 1971, 46:113-120.
6. LaBarbera D.V., Reid B.G., Yoo B.H. Expert Opin. Drug Dis. 2012, 7:819-830.
7. Reid B.G., Jerjian T., Patel P., Zhou Q., et al. Curr. Chem. Genomics Transl. Med. 2014, 8:27-35.
8. Amann A., Zwierzina M., Gamerith G., Bitsche M., et al. PLoS ONE 2014, 9:e92511.
9. Friedrich J., Ebner R., Kunz-Schughart L.A. Int. J. Radiat. Biol. 2007, 83:849-871.
10. Lin R.Z., Chang H.Y. Biotechnol. J. 2008, 3:1172-1184.
11. Abbott A. Nature 2003, 424:870-872.
12. Ghosh S., Spagnoli G.C., Martin I., Ploegert S., et al. J. Cell. Physiol. 2005, 204:522-531.
13. Han J., Chang H., Giricz O., Lee G.Y., et al. PLoS Comput. Biol. 2010, 6:e1000684.
14. Borgmann K., Zschenker O., Streichert T., Hehlgans S., et al. PLoS ONE 2012, 7:e34279.
15. Moffat J.G., Rudolph J., Bailey D. Nat. Rev. Drug Discov. 2014, 13:588-602.
16. Swinney D.C., Anthony J. Nat. Rev. Drug Discov. 2011, 10:507-519.
17. Dickinson M.E. Dev. Dyn. 2006, 235:2386-2400.
18. Bowen W.P., Wylie P.G. Assay Drug Dev. Technol. 2006, 4:209-221.
19. Horman S.R., To J., Orth A.P. J. Biomol. Screen. 2013, 18:1298-1308.
20. Horman S.R., To J., Orth A.P., Slawny N., et al. Nat. Methods 2013, 10.
21. Wylie P.G., Onley D.J., Hammerstein A.F., Bowen W.P. Assay Drug Dev. Technol. 2015, 13:66-78.
22. Benninger R.K., Piston D.W. Curr. Protoc. Cell Biol. 2013, 59:4.11.1-4.11.24.
23. Göbel W., Kampa B.M., Helmchen F. Nat. Methods 2007, 4:73-79.
24. Gilbert R.J., Hoffman M., Capitano A., So P.T.C. Microsc. Res. Tech. 2000, 51:204-210.
25. Pampaloni F., Ansari N., Stelzer E.H.K. Cell Tissue Res. 2013, 352:161-177.
26. Pampaloni F., Stelzer E.H.K., Masotti A. Recent Pat. Biotechnol. 2009, 3:103-117.
27. Pampaloni F., Richa R., Ansari N., Stelzer E.H.K. Methods Mol. Biol. 2015, 1251:43-57.
28. Pampaloni F., Berge U., Marmaras A., Horvath P., et al. Integr. Biol. 2014, 6:988-998.
29. Aftab O., Fryknäs M., Hammerling U., Larsson R., et al. J. Biomol. Screen. 2015, 20:372-381.
30. Härmä V., Schukov H.P., Happonen A., Ahonen I., et al. PLoS ONE 2014, 9:e96426.
31. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., et al. Nat. Methods 2012, 9:676-682.
32. Peng H., Bria A., Zhou Z., Iannello G., et al. Nat. Protoc. 2014, 9:193-208.
33. Peng H., Tang J., Xiao H., Bria A., et al. Nat. Commun. 2014, 5:4342.
34. Kankaanpää P., Paavolainen L., Tiitta S., Karjalainen M., et al. Nat. Methods 2012, 9:683-689.
35. Ollion J., Cochennec J., Loll F., Escudé C., et al. Bioinformatics 2013, 29:1840-1841.
36. de Chaumont F., Dallongeville S., Chenouard N., Hervé N., et al. Nat. Methods 2012, 9:690-696.
37. Linkert M., Rueden C.T., Allan C., Burel J.M., et al. J. Cell Biol. 2010, 189:777-782.
38. Cornelissen F., Cik M., Gustin E. J. Biomol. Screen. 2012, 17:496-506.
39. Wenzel C., Riefke B., Gründemann S., Krebs A., et al. Exp. Cell Res. 2014, 323:131-143.
40. Verveer P.J., Swoger J., Pampaloni F., Greger K., et al. Nat. Methods 2007, 4:311-313.
41. Keller P.J., Schmidt A.D., Santella A., Khairy K., et al. Nat. Methods 2010, 7:637-642.
42. Abd El-Rehim D.M., Pinder S.E., Paish C.E., Bell J., et al. J. Pathol. 2004, 203:661-671.
43. Axlund S.D., Yoo B.H., Rosen R.B., Schaack J., et al. Horm. Cancer 2013, 4:36-49.
44. Kabos P., Haughian J.M., Wang X., Dye W.W., et al. Breast Cancer Res. Treat. 2011, 128:45-55.
45. Kenny H.A., Lal-Nag M., White E.A., Shen M., et al. Nat. Commun. 2015, 6:6220.
46. Krausz E., de Hoogt R., Gustin E., Cornelissen F., et al. J. Biomol. Screen. 2013, 18:54-66.
47. Tuschl G., Lauer B., Mueller S.O. Expert Opin. Drug Metab. Toxicol. 2008, 4:855-870.
48. Gunness P., Mueller D., Shevchenko V., Heinzle E., et al. Toxicol. Sci. 2013, 133:67-78.
49. Meng Q. Expert Opin. Drug Metab. Toxicol. 2010, 6:733-746.
50. Huch M., Boj S.F., Clevers H. Regener. Med. 2013, 8:385-387.
51. Huch M., Dorrell C., Boj S.F., van Es J.H., et al. Nature 2013, 494:247-250.
52. van de Wetering M., Francies H.E., Francis J.M., Bounova G., et al. Cell 2015, 161:933-945.
53. Lancaster M.A., Knoblich J.A. Nat. Protoc. 2014, 9:2329-2340.